Analysis of Molecular Cytogenetic Alterations in Uterine Leiomyosarcoma by Array-based Comparative Genomic Hybridization

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2012 Mar 16

PMID 22419440

Citations 18

Authors

Mohammad Raish

Mohsin Khurshid

Mushtaq Ahmad Ansari

Pankaj Kumar Chaturvedi

Su-Mi Bae

Jang Heub Kim

Eun Kyung Park

Dong Chun Park

Woong Shick Ahn

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to identify novel genes following genomic DNA copy number changes using a genome-wide array-based comparative genomic hybridization (array-CGH) analysis in uterine leiomyosarcoma (ULMS).

Methods: Genomic DNA copy number changes were analyzed in 15 cases of ULMS from St Mary's Hospital of the Catholic University of Korea. The paraffin-fixed tissue samples were micro-dissected under microscope, and DNA was extracted. Array-based CGH and genomic polymerase chain reaction were carried out with statistical analyses such as hierarchical clustering and Gene Ontology.

Results: All of 15 cases of ULMS showed specific gains and losses. The percentage of average gains and losses were 8.4 and 16.6 %, respectively. The analysis limit of average gains and losses was 40 %. The regions of high level of gain were 1q23.3, 7p14.2, 7q34, 7q35, 7q36.3, 13q34, and 16p13.3. And the regions of homozygous loss were 2q21.1, 2q22.1, 2p23.2, 12q23.3, 4q21.22, 4q34.3, 11q24.2, 12q23.3, 13q13.1, 13q21.33, and 14q24.3. In ULMS samples, recurrent regions of gain were 1p36.33, 1p36.32, 5q35.3, 7q36.3, and 8q24.3 and recurrent regions of loss were 1p31.1-p31.3, 1p32.1-p32.3, 2p12, 2p13.3, 2p14, 2p16.2-p16.3, 2q12.1-q12.3, 2q21.1-q21.2, 2q22.2-q22.3, 2q34, 2q36.1-q36.3, 5q21.3, 5q23.3, 5q31.1, 6p11.2, 6p12.1, 10q11.23, 10q21.2-q21.3, 10q23.2, 10q23.31, 10q25.1-q25.2, 10q25.3, 10q26.13, 10q26.2-q26.3, 11p11.2, 11p11.12, 11p12, 11p13, 11p15.4, 11q23.1-q23.2, 11q23.3, 13q14.12, 13q14.13-13q14.2, 13q14.2, 13q14.2, 13q14.3, 13q21.33, 13q22.1-q22.3, 14q24.2, 14q24.3, 14q31.1, 14q32.33, 15q11.2-q13, 15q14, 16q22.3, 16q23.1, 16q23.2, 16q24.1, 20p12.1, and 21q22.3. Representative frequently gained BAC clones encoded genes were HDAC9, CRR9, SOX18, PTPRN2, SKI, SOLH, and KIAA1199. The genes encoded by frequently lost BAC clones were LOC150516 and AMY2A. A subset of cellular processes from each gene were clustered by Gene Ontology database.

Conclusions: The present study using array-CGH analyses sought a deeper elucidation of the specific genomic alterations related to ULMS. The high resolution of array-CGH combined with human genome database would give a chance at identifying relevant target genes.

Citing Articles

Comprehensive mutational profiling identifies new driver events in cutaneous leiomyosarcoma.

van der Weyden L, Del Castillo Velasco-Herrera M, Cheema S, Wong K, Boccacino J, Offord V Br J Dermatol. 2024; 192(2):335-343.

PMID: 39392932 PMC: 11758588. DOI: 10.1093/bjd/ljae386.

Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy.

Yang Q, Madueke-Laveaux O, Cun H, Wlodarczyk M, Garcia N, Carvalho K Cells. 2024; 13(13.

PMID: 38994959 PMC: 11240800. DOI: 10.3390/cells13131106.

Chitosan oligosaccharide suppresses osteosarcoma malignancy by inhibiting CEMIP via the PI3K/AKT/mTOR pathway.

Sim I, Choe W, Ri J, Su H, Adel Abdo Moqbel S, Yan W Med Oncol. 2023; 40(10):294.

PMID: 37668818 PMC: 10480286. DOI: 10.1007/s12032-023-02165-9.

Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review.

Sparic R, Andjic M, Babovic I, Nejkovic L, Mitrovic M, Stulic J Int J Mol Sci. 2022; 23(17).

PMID: 36077127 PMC: 9456512. DOI: 10.3390/ijms23179728.

Identification of Somatic Genetic Alterations Using Whole-Exome Sequencing of Uterine Leiomyosarcoma Tumors.

Chen L, Li J, Wu X, Zheng Z Front Oncol. 2021; 11:687899.

PMID: 34178683 PMC: 8226214. DOI: 10.3389/fonc.2021.687899.

References

Sait S, Dal Cin P, Sandberg A . Consistent chromosome changes in leiomyosarcoma. Cancer Genet Cytogenet. 1988; 35(1):47-50. DOI: 10.1016/0165-4608(88)90120-3. View

Mittal K, Demopoulos R . MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol. 2001; 32(9):984-7. DOI: 10.1053/hupa.2001.27113. View

Levy B, Mukherjee T, Hirschhorn K . Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet. 2000; 121(1):1-8. DOI: 10.1016/s0165-4608(00)00225-9. View

Gibas Z, Griffin C, Emanuel B . Clonal chromosome rearrangements in a uterine myoma. Cancer Genet Cytogenet. 1988; 32(1):19-24. DOI: 10.1016/0165-4608(88)90306-8. View

El-Rifai W, Sarlomo-Rikala M, Knuutila S, Miettinen M . DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol. 1998; 153(3):985-90. PMC: 1853026. DOI: 10.1016/S0002-9440(10)65640-4. View

Morton C . Warner-Lambert/Parke-Davis Award lecture. Many tumors and many genes: genetics of uterine leiomyomata. Am J Pathol. 1998; 153(4):1015-20. PMC: 1853042. DOI: 10.1016/s0002-9440(10)65645-3. View

Quade B, Pinto A, Howard D, Peters 3rd W, Crum C . Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma. Am J Pathol. 1999; 154(3):945-50. PMC: 1866411. DOI: 10.1016/S0002-9440(10)65342-4. View

Dei Tos A, Maestro R, Doglioni C, Piccinin S, Libera D, Boiocchi M . Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol. 1996; 148(4):1037-45. PMC: 1861534. View

Walker C, Stewart E . Uterine fibroids: the elephant in the room. Science. 2005; 308(5728):1589-92. DOI: 10.1126/science.1112063. View

10.

Packenham J, Du Manoir S, Schrock E, Risinger J, Dixon D, Denz D . Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization. Mol Carcinog. 1997; 19(4):273-9. DOI: 10.1002/(sici)1098-2744(199708)19:4<273::aid-mc9>3.0.co;2-d. View

11.

Krzywinski M, Bosdet I, Smailus D, Chiu R, Mathewson C, Wye N . A set of BAC clones spanning the human genome. Nucleic Acids Res. 2004; 32(12):3651-60. PMC: 484185. DOI: 10.1093/nar/gkh700. View

12.

Mark J, Havel G, Grepp C, Dahlenfors R, Wedell B . Cytogenetical observations in human benign uterine leiomyomas. Anticancer Res. 1988; 8(4):621-6. View

13.

Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T . Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer. 1997; 20(4):399-407. View

14.

Tsibris J, Segars J, Coppola D, Mane S, Wilbanks G, OBrien W . Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil Steril. 2002; 78(1):114-21. PMC: 4143900. DOI: 10.1016/s0015-0282(02)03191-6. View

15.

Tagawa H, Tsuzuki S, Suzuki R, Karnan S, Ota A, Kameoka Y . Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases. Cancer Res. 2004; 64(17):5948-55. DOI: 10.1158/0008-5472.CAN-03-4056. View

16.

Cho Y, Bae S, Koo M, Kim K, Chun H, Kim C . Array comparative genomic hybridization analysis of uterine leiomyosarcoma. Gynecol Oncol. 2005; 99(3):545-51. DOI: 10.1016/j.ygyno.2005.07.017. View

17.

Wechsler D, Shelly C, Dang C . Genomic organization of human MXI1, a putative tumor suppressor gene. Genomics. 1996; 32(3):466-70. DOI: 10.1006/geno.1996.0144. View

18.

Knuutila S, Bjorkqvist A, Autio K, Tarkkanen M, Wolf M, Monni O . DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol. 1998; 152(5):1107-23. PMC: 1858578. View

19.

Ashar H, Fejzo M, Tkachenko A, Zhou X, Fletcher J, Weremowicz S . Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell. 1995; 82(1):57-65. DOI: 10.1016/0092-8674(95)90052-7. View

20.

Schoenmakers E, Wanschura S, Mols R, Bullerdiek J, Van Den Berghe H, Van de Ven W . Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet. 1995; 10(4):436-44. DOI: 10.1038/ng0895-436. View